| Sales | 23.64B |
| Costs, Expenses and Other | |
| Materials and production | 5.59B |
| Marketing and administrative | 7.32B |
| Research and development | 5.14B |
| Restructuring costs | 545.6M |
| Equity income from affiliates | -2.5B |
| Other (income) expense, net | -3.28B |
| Total Costs, Expenses and Other | 12.82B |
| Income Before Taxes | 10.82B |
| Taxes on Income | 2.75B |
| Net Income | 8.08B |
| Less: Net Income Attributable to Noncontrolling Interests | 122.8M |
| Net Income Attributable to Merck & Co., Inc. | 7.95B |
| Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders | |
| Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders | |
| Dividends Declared per Common Share | |